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Abstract
By regulating the timing of cellular processes, the circadian clock provides a way to adapt
physiology and behaviour to the geophysical time. In mammals, a light-entrainable master
clock located in the suprachiasmatic nucleus (SCN) controls peripheral clocks that are
present in virtually every body cell. Defective circadian timing is associated with several
pathologies such as cancer and metabolic and sleep disorders. To better understand the
circadian regulation of cellular processes, we developed a bioinformatics pipeline encom-
passing the analysis of high-throughput data sets and the exploitation of published knowl-
edge by text-mining. We identified 118 novel potential clock-regulated genes and
integrated them into an existing high-quality circadian network, generating the to-date
most comprehensive network of circadian regulated genes (NCRG). To validate particular
elements in our network, we assessed publicly available ChIP-seq data for BMAL1, REV-
ERBα/β and RORα/γ proteins and found strong evidence for circadian regulation of
Elavl1, Nme1, Dhx6,Med1 and Rbbp7 all of which are involved in the regulation of tumour-
igenesis. Furthermore, we identified Ncl and Ddx6, as targets of RORγ and REV-ERBα, β,
respectively. Most interestingly, these genes were also reported to be involved in miRNA
regulation; in particular, NCL regulates several miRNAs, all involved in cancer aggres-
siveness. Thus, NCL represents a novel potential link via which the circadian clock, and
specifically RORγ, regulates the expression of miRNAs, with particular consequences in
breast cancer progression. Our findings bring us one step forward towards a mechanistic
understanding of mammalian circadian regulation, and provide further evidence of the in-
fluence of circadian deregulation in cancer.
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Introduction
Almost all organisms evolved an endogenous circadian clock which regulates the timing of cen-
tral biological processes and provides a way to adapt physiology and behaviour to daily dark/
light rhythms [1–3]. In mammals, malfunctions of the circadian system are associated to
known pathologies ranging from sleep or metabolic disorders, to cancer [4–6]. Hence, a de-
tailed overview of the underlying genetic network that shapes the mammalian circadian system
is of major interest to the circadian and medical field.
The mammalian circadian system is hierarchically organized. A main pacemaker formed by
two clusters of ~100,000 neurons (in humans) is located in the suprachiasmatic nucleus (SCN),
but peripheral oscillators exist in virtually every of our 3.5×1013 body cells [7, 8]. Extensive re-
search has identified a reduced set of 14 genes to form the so called core-clock network (CCN),
within a cell. These genes encode for members of several gene families: PER (period), CRY
(cryptochrome), BMAL (brain and muscle ARNT-like protein), CLOCK (circadian locomotor
output cycles kaput), NPAS2 (neuronal PAS domain-containing protein 2, in neuronal tissue),
ROR (retinoic acid receptor-related orphan receptor) and REV-ERB (nuclear receptor, reverse
strand of ERBA). The CCN is arranged in two main interconnected feed-back loops: a) the
RORs/Bmal/REV-ERBs (RBR) loop and b) the PERs/CRYs (PC) loop [9]. Both loops are able
to produce rhythms in gene expression, independently, but need to be interconnected to ro-
bustly generate oscillations with a period of circa 24 hours [10, 11]. In the centre of the core-
clock network lays the heterodimer complex CLOCK/BMAL1. This complex regulates the
transcription of elements of both the RBR and PC loop by binding to E-Box sequences in the
promoter region of the target genes. In the RBR-loop, Rev-Erbα,β and Rorα,β,γ are transcribed.
After translation, the resulting proteins compete for RORE elements within the Bmal1 promot-
er region and hold antagonistic effects, thereby fine-tuning Bmal1 expression. In the PC loop,
following transcription and translation, PER1,2,3 and CRY1,2 form complexes and inhibit
CLOCK/BMAL mediated-transcription, thus regulating the expression of all target genes
mentioned above.
The CCN has been studied, on a fine scale, at the transcriptional, translational and post-
translational level both experimentally and with mathematical models [9, 12–18]. Furthermore,
various efforts have been made to decipher the mechanisms through which the mammalian
CCN regulates its target genes, the clock-controlled genes (CCG), as well as to identify new
CCGs [19–21]. Yet, a more detailed knowledge on the full range of genes and subsequent bio-
logical processes that are regulated by the core of the circadian clock is still missing. Therefore,
a comprehensive analysis of the relevance of such connections, as well as on the putative effects
of deregulations on circadian output and resulting pathological phenotypes, is needed.
In this manuscript, we present a comprehensive mammalian circadian network constructed
by an integrated bioinformatics pipeline which uses different data sources and different data
types. This novel circadian network topology highlights particularly genes which link the circa-
dian clock to several biological processes, often in multiple alternative ways. We carried out a
systematic expansion of a previously published core-clock network (ECCN) using gene co-ex-
pression analysis, text-mining on the full PubMed, signatures of circadian expression patterns,
and ChIP-Seq data. We used the first two of these methods to identify a set of 118 novel high-
confidence ECCN target genes, whereas the latter two data types were used for validation of
this set, which resulted in a novel network of circadian regulated genes (NCRG) (Fig 1). In par-
ticular, ChIP-seq data for BMAL1, RORα,γ and REV-ERBα,β [12, 15–17, 22] confirmed links
between the ECCN and several cancer-related genes. Notably, two of these genes were shown
to be involved in miRNA regulation.
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Altogether, our findings suggest, new potential clock genes and describe their role and to-
pology within the circadian network. Our work delivers novel evidence to the influence of cir-
cadian deregulation in cancer and adds a novel way via which a clock-dependent cancer output
may emerge, i.e., miRNA circadian regulation.
Fig 1. Work flow used to establish a network of circadian regulated genes (NCRG). Two independent data types were used to predict genes which
interact with the human core clock network (CCN, orange) and the extended core clock network (ECCN, green). Co-expression data was used to find sets of
genes with strongest (anti-) correlating expression with the 43 ECCN genes across a large number of independent experiments. A total of 2357 genes were
found to interact with more than 2 ECCN genes. The GeneView text-mining pipeline was used to analyse published knowledge (approximately 22 million
citations) about interacting genes. A total of 961 text-mining-predicted genes were found. The intersection of both methodologies resulted in 118 new genes,
which together with the ECCN form a new network of circadian regulated genes (NCRG, purple).
doi:10.1371/journal.pone.0126283.g001
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Results
A text-mining based approach for network discovery
We aimed to update and extend our recently reported circadian network (ECCN-extended
core-clock network) [21]. For that we combined the results of a text-mining system with high-
throughput gene co-expression data to obtain new elements and interactions. This procedure
resulted in a network of circadian regulated genes (NCRG) following the workflow schema-
tized in Fig 1.
The original ECCN [21] contains a core of 14 well known circadian genes, Per1,2,3, Cry1,2,
Bmal1,2, Rorα,β,γ and Rev-Erbα,β as well as Clock, its paralog Npas2, and their direct neigh-
bouring targets. We started our study by generating an update version of the ECCN using the
text-mining software—GeneView (see Materials and Methods) [23] to extract all pairwise in-
teractions among our genes of interest and their directly interacting neighbours. The new
ECCN contains 43 elements as the previous network [21], the depicted interactions were up-
dated to the current PubMed available data resulting in more than 200 regulatory relationships
(Fig 2). Additional information containing all interactions and corresponding references, as
well as a more detailed characterization of the ECCN is provided in S1 Table and S1
Text, respectively.
Co-expression data analysis confirms the ECCN network topology
In this work we expanded the updated ECCN with a new layer of potentially ECCN-regulated
elements (genes and proteins) using co-expression data as a first source of evidence. We con-
sider as such candidates all genes which show a strong co-expression to ECCNmembers and
which can be confirmed using text-mining, as indicated in Fig 1.
There are several public available databases providing co-expression metrics for human
genes, we evaluated four different such databases [24–26] regarding their ability to reproduce
the ECCN, to find the best suited for our analysis. Results of our comparisons are presented in
S2 Text. We eventually choose COXPRESdb [25] (see Fig 3), as this database showed the high-
est degree of correlation within all genes of the extended core-clock network.
We expected a significant difference between the correlation measure distributions of inter-
acting gene pairs and a chosen background, if unknown interacting pairs were to be predicted
based on correlation values. All possible pairs between a random set of 43 genes and all genes
(19,788) were used as background. As foreground pairs we used the 42 known available inter-
actions amongst the CCN genes, as well as the 119 curated interactions of the ECCN gene set.
Both the CCN (orange) and ECCN (green) gene pairs tended to have higher correlations com-
pared to the random background and thus lower mutual rank (MR) values (Fig 3A and 3B and
S1 Fig). The probability density functions of correlation and mutual rank are shown in S2 Fig
for both datasets. All correlation values were Fisher transformed to ensure normal distribution
prior to hypothesis testing to characterize differences between the CCN, ECCN, and the back-
ground. Subsequent one-sided t-tests with the alternative hypothesis to observe smaller corre-
lations in the background confirmed the results of the visual inspection: CCN gene pairs are
significantly higher correlated than the background pairs (p< 0.0195) similar to the ECCN
gene pairs (p< 6e-7). Similarly significant differences were observed in the Hsa dataset for the
CCN (p< 1.4e-3) and the ECCN (p< 1.2e-7). Furthermore, no significant difference was
found between correlations in the CCN and the ECCN for the Hsa (p< 0.41) and the Hsa2
dataset (p< 0.18).
Studying the co-expression of ECCN genes in detail, we observed anti-correlated circadian
expression profiles between Per and Bmal, which is consistent with the predicted 9h delay
A Comprehensive Regulatory Network for the Mammalian Circadian Clock
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between the mRNAs peak expression for these genes [9]. The strongest anti-correlation was de-
termined between ρHSA2(Bmal1,Per3) = -0.21 and the weakest between ρHSA2(Bmal2,Per2) =
-0.054. For the expected expression-correlation between Ror and Rev-Erb (circa 7h delay), we
determined weaker anti-correlations, with ρHSA2(Rev-Erbβ,Rorγ) = -0.04, ρHSA2(Rev-Erbα,
Rorγ) = 0.06, and ρHSA2(Rev-Erbα,Rorα) = 0.16. We could also validate the expected positive
correlation between Per and Cry, specifically for Per2/Cry2 with ρHSA2(Per2,Cry2) = 0.31. For
other Per and Cry family members, smaller correlation values were found with ρHSA2(Per2,
Cry1) = 0.12, and ρHSA2(Per1,Cry1) = 0.0022.
Next, we tested whether the distribution of correlations between pairs of reported interact-
ing ECCN genes could be distinguished from all other possible pairs of ECCN genes. The
known interactions exhibited positive ρHSA2 values and thus lower MR (Fig 3C and 3D). How-
ever, only a weak tendency of known interactions towards higher correlations compared to
Fig 2. The human core clock network (CCN) and the extended core clock network (ECCN). The CCN
(orange) contains the known core-clock elements (Per1,2,3, Cry1,2, Rev-Erbα,β, Rorα,β,γ, Bmal1,2, Clock
and Npas). The ECCN (green) was obtained after an extensive collection of CCN-interacting genes followed
by a detailed curation for direct interactions [21] and a further update to the recent literature. Activation (green
lines), inhibition (red lines) and other sort of interactions (grey lines) are represented. The resulting clock
network contains 43 elements and more than 200 regulatory relationships.
doi:10.1371/journal.pone.0126283.g002
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non-reported pairs can be observed (probability density functions shown in S3 Fig). The corre-
sponding comparisons of correlation distributions via t-tests confirmed the weak tendency in
the Hsa2 dataset (p< 0.059) whereas no signal was found in the Hsa dataset (p< 0.395). As a
consequence, we conclude that known interacting gene pairs cannot reliably be distinguished
Fig 3. Correlation distributions for clock network gene pairs versus random gene pairs. The cumulative Pearson ρ distributions of pairs of ECCN
genes reported to interact but excluding CCN (ECCN, green), reported pairs of CCN genes (CCN, orange), and 43 randomly chosen genes versus all genes
as background (BG, black) are shown for the Hsa2 data collection (A, B). Distributions are shown centred around 0 with the centred bin marked by the
dashed red line. The Pearson ρ distributions of reported pairs of ECCN genes (green) is compared to not reported pairs (blue) for the data set Hsa2 (C, D).
Comparison of Pearson ρ and mutual rank (E, F) between all possible pairs of ECCN genes (green) and all possible pairs of non-ECCN genes as
background (black). All data were taken from the Hsa2 data collection.
doi:10.1371/journal.pone.0126283.g003
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from other pairs within the ECCN based merely on expression correlation. We then tested the
assumption that expression patterns are generally higher correlated within the ECCN as com-
pared to other non-ECCN gene pairs. The resulting distributions for Pearson ρ and mutual
rank between all possible pairs of the ECCN genes included in the datasets, as compared to all
combinations of the same genes with all other genes are shown in Fig 3E and 3F (probability
density functions shown in S4 Fig). We confirmed the difference of the ECCN set as compared
to the background set as before with t-test which yielded high significance in both datasets
(p< 2.2e-16). In addition, the corresponding mutual rank measures were also found to be sig-
nificantly lower (Wilcoxon Rank Sum test, p< 2.2e-16). Hence, we concluded that the exam-
ined expression correlation data provided information about the membership of a gene to the
clock network, but not about the network’s topology.
Expression correlation-based target prediction
We selected the 10.000 highest correlating pairs of one of the 43 ECCN genes and any other
gene. This conservatively chosen threshold selects 1.18% of all pairs, corresponding to an abso-
lute correlation cut-off of 0.3636, or 2.6 σ. In this set, the number of unique new genes was
4.183. As we sought to investigate genes that were tightly associated with the ECCN (i.e. associ-
ated with multiple ECCN genes). We defined tightness as the number of connections between
a gene and the ECCN and sought to find the largest number of tightly connected predicted tar-
gets by filtering them at several levels of minimum tightness. At increasing levels of minimum
tightness, we performed an overrepresentation analysis of GO and KEGG terms for varying
minimal values of these counts. The largest changes in overrepresented terms occurred when
changing the threshold from one to two (Fig 4). There, terms related to cell cycle and the
Fig 4. Variation in functional annotation enrichment with increasing tightness between the predicted targets and the ECCN. The significance of 28
enriched GO terms (A) and 16 KEGG terms (B) for genes connected to the CCN steadily decreases for most terms as the minimum number connections is
increased (this number of connections between a gene and a gene set is here defined as "tightness"). As the minimum tightness between the predicted
targets and the ECCN increases, the enrichment and rank of functional annotation changes. We observe an overall decrease in enrichment but little in rank.
The greatest changes in rank occur between a tightness of 2 and 3. At a tightness of two and above, the rank of the majority of significant GO terms such as
"mitotic cell cycle" and "nuclear mRNA splicing, via spliceosome", and KEGG terms such as "Spliceosome", "Ubiquitin mediated proteolysis" and "RNA
degradation" remain largely stable suggesting a natural threshold on tightness at this point.
doi:10.1371/journal.pone.0126283.g004
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ribosome rapidly dropped in significance, while, terms related to splicing and transcription
largely retained their position. When increasing the tightness further, much smaller
changes occurred.
Accordingly, we defined tightly connected genes as those having two or more associations
with the ECCN, which reduced the number of predicted ECCN targets from 4,183 to 2,357
with 8,180 interactions (S5 Fig).
The number of tightly connected genes associated to a given ECCN element varied greatly.
While 11 ECCN members did not feature any interaction, the three elements CREB, AMPK,
and CLOCK covered 48% of all predicted interactions (S6 Fig).
Gene ontology terms (GO) and KEGG pathway enriched in this set are listed in Table 1 and
Table 2, respectively. To obtain an insight into which ECCN genes are of particular importance
for the enriched function or pathway, we determined the cross table for each combination of
ECCN gene versus enriched term, counting the number of predicted target genes featuring the
corresponding term. This approach yielded a consistent pattern for GO functional annotations
(50 terms with q< 0.01) and KEGG pathways (35 pathways with q< 0.01) (Fig 5). About half
of the ECCN genes were associated with a multitude of genes covering a range of GO annota-
tions, while the other half was associated with few genes covering only a small number of GO
terms (Fig 5A). The largest number of target genes was annotated with the molecular function
“protein binding” and the cellular component “nucleus”. The second-strongest molecular func-
tion signal was “DNA binding”. The most striking association was found between the genes
Csnk2a,Wdr5, Nono, and Parp-1 and the spliceosome (q< 1.5e-37) and RNA transport
(q< 8e-38) pathways, where q represent the p-value adjusted by Benjamini-Hochberg multiple
testing correction. These genes were also predicted to target ribosome biogenesis, cell cycle,
and purine/pyrimidine synthesis related genes. Another strong association was found between
cancer-related pathways such as “Pathways in cancer” (q< 7e-7),”Wnt signalling” (q< 2.8e-8),
“MAPK signalling” (q< 4e-6), and the Ampk and Creb target genes (Fig 5B).
An extended network of circadian regulation: beyond the core
We used text-mining to obtain a second set of genes potentially regulated by the ECCN, and
then compared this set to the 2357 genes obtained from co-expression analysis (Fig 1). First,
we obtained from GeneView the 50 most frequent interaction partners for each ECCN element,
resulting in 961 new interacting genes, each supported by 55 sentences on average. These genes
and their supporting sentences are given in S2 Table. The analysis of a large set of GeneView-
output sentences revealed 20% of wrong sentences which corresponded to 10% false-positive
interactions. Again, we subjected this gene set to enrichment analysis. A large number of signif-
icantly enriched annotations were observed in the analysis of GO terms (154 terms with
q< 0.01) and KEGG pathways (115 pathways with q< 0.01) (S3 and S4 Tables). The top 4
GO terms (q< 7.6e-18) included positive and negative regulation of transcription from RNA
polymerase II promoters (GO:0045944, GO:0000122), indicating a large fraction of transcrip-
tion regulatory genes in this set. The term “anti-apoptosis” was listed on the 7th position
(q< 7.5e-13) with 64 annotations found, where only 16 are expected by chance. The top-three
enriched KEGG annotations were “Pathways in cancer” (q< 1.6e-92), “Cytokine-cytokine re-
ceptor interaction” (q< 3e-34), and “Toll-like receptor signalling pathway” (q< 2.6e-35), with a
range of cancer-related pathways following.
Intersecting the ECCN-interacting gene sets predicted by expression correlation (n = 2357)
and text-mining (n = 961), respectively, resulted in a set of 118 genes (Fig 6A). While 38 novel
interactions with an ECCN gene were predicted by both methods, 364 interactions were co-ex-
pression-specific and 182 were text-mining-specific (S5 Table). Interestingly, enrichment
A Comprehensive Regulatory Network for the Mammalian Circadian Clock
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Table 1. Enrichment analysis of the co-expression-predicted ECCN interacting genes for GO term annotations.
GO Term Annotations in Total Annotations in Predicted Set Expected FDR
nuclear mRNA splicing, via spliceosome 200 88 27 1.9e-10
cell division 443 114 59.81 1.6e-09
mRNA transport 105 54 14.18 6.7e-08
DNA strand elongation involved in DNA replication 34 21 4.59 1.2e-06
ubiquitin-dependent protein catabolic process 347 104 46.85 1.7e-06
S phase of mitotic cell cycle 130 44 17.55 1.8e-06
regulation of glucose transport 69 24 9.32 1.9e-06
mitotic prometaphase 84 35 11.34 1.9e-06
M/G1 transition of mitotic cell cycle 76 32 10.26 8.4e-06
mRNA processing 378 152 51.03 1.9e-05
gene expression 4347 874 586.86 0.00027
cell cycle checkpoint 234 70 31.59 0.00031
DNA duplex unwinding 28 18 3.78 0.00033
nuclear-transcribed mRNA poly(A) tail shortening 26 16 3.51 0.00038
mRNA export from nucleus 59 28 7.97 0.00042
protein transport 1154 222 155.79 0.00047
DNA-dependent DNA replication initiation 28 16 3.78 0.00079
DNA repair 369 109 49.82 0.00120
termination of RNA polymerase II transcription 44 20 5.94 0.00285
regulation of transcription, DNA-templated 2735 506 369.23 0.00518
RNA splicing 308 121 41.58 0.00989
protein binding 6831 1116 889.85 2.6e-29
RNA binding 792 248 103.17 7.0e-24
DNA binding 2240 454 291.8 5.8e-14
ATP binding 1439 292 187.45 9.4e-13
nucleotide binding 2294 448 298.83 3.3e-07
ubiquitin thiolesterase activity 64 27 8.34 2.6e-05
chromatin binding 235 59 30.61 0.00026
ubiquitin-protein ligase activity 241 63 31.39 0.00104
translation initiation factor activity 50 21 6.51 0.00134
ubiquitin-speciﬁc protease activity 43 19 5.6 0.00186
ATP-dependent DNA helicase activity 32 17 4.17 0.00547
protein transporter activity 87 28 11.33 0.00865
nucleus 5640 1172 724.54 2.1e-30
nucleoplasm 1401 423 179.98 1.0e-27
nuclear speck 144 61 18.5 1.3e-15
nucleolus 589 154 75.67 2.4e-14
catalytic step 2 spliceosome 78 40 10.02 3.7e-13
nuclear pore 60 36 7.71 5.6e-10
cytosol 2217 382 284.8 3.6e-07
heterogeneous nuclear ribonucleoprotein complex 19 14 2.44 2.5e-06
centrosome 363 89 46.63 3.9e-05
Cajal body 44 20 5.65 0.00014
cytoplasmic stress granule 21 12 2.7 0.00239
spliceosomal complex 137 60 17.6 0.00322
nuclear pore outer ring 10 8 1.28 0.00330
chromatin 280 72 35.97 0.00466
(Continued)
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Table 1. (Continued)
GO Term Annotations in Total Annotations in Predicted Set Expected FDR
DNA replication factor C complex 6 6 0.77 0.00568
chaperonin-containing T-complex 6 6 0.77 0.00568
nuclear membrane 169 46 21.71 0.00685
Gene ontology annotation enrichment was performed for the molecular function, cellular component, and biological process ontologies. Only terms with
q < 0.01 (false discovery rate after Benjamini-Hochberg) are shown.
doi:10.1371/journal.pone.0126283.t001
Table 2. Enrichment of KEGG pathway annotations amongst the co-expression-predicted ECCN in-
teracting genes.
KEGG ID Pathway p-value FDR
hsa03013 RNA transport 3.51E-40 8.00E-38
hsa03040 Spliceosome 6.64E-40 1.50E-37
hsa04110 Cell cycle 7.95E-23 1.80E-20
hsa03008 Ribosome biogenesis in eukaryotes 6.98E-21 1.60E-18
hsa04120 Ubiquitin mediated proteolysis 4.01E-16 9.00E-14
hsa03018 RNA degradation 1.95E-14 4.40E-12
hsa03030 DNA replication 6.08E-14 1.40E-11
hsa03015 mRNA surveillance pathway 8.00E-12 1.80E-09
hsa04141 Protein processing in endoplasmic reticulum 2.52E-11 5.60E-09
hsa04310 Wnt signalling pathway 1.26E-10 2.80E-08
hsa05200 Pathways in cancer 3.19E-09 7.00E-07
hsa04740 Olfactory transduction 6.69E-09 1.50E-06
hsa03430 Mismatch repair 8.92E-09 1.90E-06
hsa00230 Purine metabolism 1.24E-08 2.70E-06
hsa00240 Pyrimidine metabolism 1.24E-08 2.70E-06
hsa04010 MAPK signalling pathway 1.84E-08 3.90E-06
hsa03420 Nucleotide excision repair 6.15E-08 1.30E-05
hsa05220 Chronic myeloid leukemia 2.60E-07 5.50E-05
hsa04722 Neurotrophin signalling pathway 2.94E-07 6.20E-05
hsa04144 Endocytosis 5.12E-07 1.10E-04
hsa04114 Oocyte meiosis 7.00E-07 1.50E-04
hsa05210 Colorectal cancer 7.63E-07 1.60E-04
hsa04660 T cell receptor signalling pathway 1.16E-06 2.40E-04
hsa05213 Endometrial cancer 2.74E-06 5.70E-04
hsa04914 Progesterone-mediated oocyte maturation 3.32E-06 6.80E-04
hsa04720 Long-term potentiation 3.78E-06 7.70E-04
hsa05160 Hepatitis C 1.04E-05 2.10E-03
hsa04810 Regulation of actin cytoskeleton 1.17E-05 2.40E-03
hsa04012 ErbB signalling pathway 1.38E-05 2.80E-03
hsa05216 Thyroid cancer 1.42E-05 2.80E-03
hsa04910 Insulin signalling pathway 1.45E-05 2.90E-03
hsa05211 Renal cell carcinoma 1.76E-05 3.50E-03
hsa03050 Proteasome 1.95E-05 3.80E-03
hsa05223 Non-small cell lung cancer 2.30E-05 4.50E-03
hsa03450 Non-homologous end-joining 5.12E-05 1.00E-02
Only terms with q < 0.01 (false discovery rate after Benjamini-Hochberg) are shown.
doi:10.1371/journal.pone.0126283.t002
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Fig 5. Homogenous functional spectrum of genes targeted by different ECCN genes. The specific functions of genes interacting with each individual
ECCN gene were counted and illustrated as heat map. Annotated KEGG pathways (A) and GO terms (B) found to be overrepresented amongst all predicted
target genes in the preceding analysis were counted for each target gene, and these counts were then accumulated for each individual ECCN gene and
represented as colours according to the legend. Rows and columns are ordered according to a hierarchical clustering.
doi:10.1371/journal.pone.0126283.g005
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analysis of the 118 target genes using KEGG annotations indicated a strong connection to sig-
nalling- and cancer-related pathways (Fig 6B). The GO enrichment yielded the terms “telomere
maintenance” and “peptidyl-serine phosphorylation” as significantly enriched biological pro-
cesses (Fig 6C). The molecular function “ligand-dependent nuclear receptor binding” was also
found to be significantly enriched (q< 0.0009).
Finally, we used this intersection of the text-mining analysis and co-expression analysis to
extend the ECCN, resulting in a novel network of circadian regulated genes (NCRG) compris-
ing 161 genes all together (Fig 7). An additional 220 interactions between the ECCN and the
new NCRG were found amongst the text-mining dataset and 402 interactions within the co-ex-
pression data. The number of correlation-based interactions is less informative because, as we
have shown above it is not a precise method to infer network topology. Since this assessment
was derived from a mixture of various tissue types, the NCRG can be expected to be an aggre-
gation of different tissue-specific interactions.
Circadian phenotype amongst predicted ECCN extension genes
We tested how many of the 118 novel ECCN targets were found to exhibit circadian expression
patterns in circadian data sets [14, 27]. Integration of these two mouse datasets, and mapping
to human genes via HomoloGene yielded a total of 1771 circadian transcripts. These included
the following 19 out of our 118 predicted targets (for p< 0.009, for p< 0.05 we find 59% genes
out of the 118-set to be circadian): Adam17, Apoh, Avp, Chd4, Clk1, Cops2, Ddx6, Dhx9,
Dnm1l,Hnrnpm, Ifnar1,Map4k3, Ncl, Nmt1, Ncoa1,Psen1, Phb2, Smad4, Sumo1 (Table 3).
Additionally, we were interested in the possible consequences of perturbing the newly
identified genes in the circadian phenotype and checked whether any of the 118 predicted
Fig 6. Functional analysis of the consensus predicted ECCN target gene set.Overlap between 2357 new ECCN elements (orange) based on
expression pattern correlation and 961 genes obtained with text-mining methods (green) (A). This resulted in 118 new genes found by both methods. KEGG
pathway annotation enrichment of the 118 consensus predicted genes (B) and corresponding GO enrichment (C).
doi:10.1371/journal.pone.0126283.g006
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ECCN-interacting genes were found to cause perturbations on the circadian clock in available
siRNA datasets [28, 29]. We found hits for different circadian phenotypes a) long-period phe-
notype: Csnk1a1 (casein kinase 1, A 1),Mapk8 (mitogen-activated protein kinase 8), Ncl
(nucleolin); b) high-amplitude phenotype: Ddb1 (damage-specific DNA binding protein 1); and
c) short-period phenotype: Cops2 (COP9 signalosome subunit 2). Among these, Ncl and Cops2
also showed a circadian expression pattern. Ncl yielded a JTK q-value of 6.16e-06, a period of
24h, and a phase of 18.5. Cops2 yields a p-value of 0.007, a period of 28h, and phase 2.5. These
findings are summarized in Table 3.
Fig 7. Network representation of CCN/ECCN network together with the 118 predicted target genes
(NCRG). Boxes represent individual genes, which are connected by lines reflecting interactions that are
known (grey), predicted by co-expression (blue), text-mining (green), or by both (red). The sub-networks are
indicated by rectangles, the CCN (orange), the ECCN (green), and NCRG (purple).
doi:10.1371/journal.pone.0126283.g007
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We further compared our findings with a recent list of 1000 genes classified as—“sufficiently
similar”—to known clock genes by a machine learning approach on a combination genome-
scale datasets from mouse fibroblast cell lines [29]. One quarter of these genes were also con-
tained in at least one of our gene sets (253 of 993 with a homolog in the human genome), and
10 genes were also detected by our text-mining and co-expression analysis: Atf2, Ddx6, Dhx9,
Elavl1, Hspa4, Ncl, Nme1,Med1, Rbbp7, Dnm1l. Out of these, the four genes Ddx6, Dhx9, Ncl,
and Dnm1l exhibit a circadian expression pattern.
Clock target genes could be validated with ChIP-seq data
To further validate our 118 consensus genes gained from the bioinformatics approach, we ex-
amined the publicly available ChIP-seq datasets for REV-ERBα/β [16, 17]. Additionally, a
BMAL1 dataset [12] was considered. ChIP-seq peak locations were used to calculate an associ-
ation score (“ClosestGene” [30]) for each gene to the corresponding transcription factor. Sim-
ple threshold calculation then yielded a TF-target prediction. The gene association score Sg,tf
was calculated for all annotated refSeq genes of the mouse genome build used in the corre-
sponding experiment. The resulting log2 transformed Sg,tf distributions are shown in S7 Fig.
The threshold for accepting a TF—gene association was chosen as 3, which yields the higher
second gene-score peak in case of the bimodal REV-ERBβ peak set, or the prominent right
shoulder of the distribution for all other peak sets (S7 Fig). A total of 3847 predicted
REV-ERBα and 3388 REV-ERBβ target genes [16] were found. The alternative dataset provid-
ed 4618 target genes associated with REV-ERBα/β unspecific peaks [17]. Lastly, this procedure
yielded 223 significant BMAL1 target genes [12]. Since the ChIP-seq peak location data for
RORα and γ, were not accessible, we relied on the list of predicted targets provided by the au-
thors based on a less stringent target prediction method [22, 31].
Overall, we obtained a set of 118 genes potentially regulated by the ECCN. Of those, 19 ex-
hibited circadian expression patterns, 5 exhibited phenotypic changes in the clock when tar-
geted with RNAi, 59 were targeted by REV-ERBα/β, and 14 were targeted by RORα or γ.
Additionally, the two NCRG genes Ddb1 andMapk8 were found to associate with BMAL1
binding sites. These findings are summarized in Table 3 and depicted in Fig 8, (see S7 Table for
all annotations).
Discussion
The mammalian circadian clock is an endogenous, time-generating system with the peculiarity
of synchronizing and propagating time-cues to the entire organism. Its relevance in the time-
dependent regulation of biological processes has been shown at the organismal and cellular lev-
els. As such, it is of no surprise that malfunctions of the circadian system were found to be asso-
ciated to pathological phenotypes including obesity, sleep disorders and increasing incidence
of cancer. The prospect of using individual patient-timing, based on the internal circadian
clock, for therapy optimization is being explored with promising results. For instance, advances
in chronotherapy have proven to be efficient in reducing toxicity and increasing efficacy in
some types of cancer, particularly colon cancer [32]. A more detailed knowledge of the circadi-
an network including the pathways it regulates is of major importance for the analysis on how
time effects may be propagated and to determine the time-dependent action of certain drugs.
In this work we set up to dissect such clock-regulated pathways and to analyse the extent of
circadian regulation at the cellular level by expanding the core circadian network to its poten-
tial target genes. We used human high-throughput transcriptome-data sets associated to text-
mining of biomedical literature, for de novo clock regulated gene discovery.
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A network of circadian regulation: combining independent evidences
Gene co-expression has previously been used to predict gene functions. Such works rely on the
Pearson correlation coefficient and extensions of it and, although able to predict gene functions
in mammals, are limited in terms of de novo network generation [24, 25]. We observed that re-
portedly interacting ECCN genes feature correlation values which are similar to non-reported.
This is a limitation of co-expression methodologies and the problem of erroneous transitive
Fig 8. Transcriptional regulation of the CCN/ECCN extension network of 118 genes by REV-ERB and
ROR. Regulatory interactions of REV-ERB α/β with NCRG genes (green lines) were derived from the
locations of physical binding of these proteins in two ChIP-seq experiments [16, 17]. The ROR α/ γ
interactions (purple lines) were adopted from the report of a third ChIP-seq experiment [22]. Genes with an
observed phenotype in the genome-wide RNAi screen [28, 29] are shown with a coloured box, red indicating
long period, blue a high amplitude, and green a short period.
doi:10.1371/journal.pone.0126283.g008
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links inferred by correlation analysis was described before [33]. Therefore, we used a hybrid-
methodology where to the expression correlation data we associated the text mining as an inde-
pendent source of knowledge, enabling us to find regulated genes and their connection to the
ECCN with increased confidence (Fig 1). This allowed us to partially overcome the limitations
of expression analysis in terms of network topology and to be able to generate a semi-regulato-
ry network for the mammalian circadian clock. Still, we do not analyse tissue-specificity issues
which go beyond the scope of this work. Nevertheless, the circadian clock has been reported, in
mammals, to be present in all cells so that the core network is expected to be very similar [34].
The output genes in the large network might indeed show tissue-specific differences which will
be very interesting to explore in future work.
Biological significance and impact in tumourigenesis
The detailed analysis of the network generated by our pipeline (NCRG) strengthens previous
findings which associate the circadian clock to regulation of several molecular processes such
as mRNA processing, cell division, cell cycle progression and DNA repair [19, 21, 35–40]. Par-
ticular pathways, including RNA transport, splicing and several cancer related pathways were
identified by our study as being significantly associated with the circadian clock, highlighting
the important function of the circadian system in the regulation of cellular processes. By com-
paring the difference in overrepresented terms between genes tightly- and those loosely-associ-
ated to the ECCN, we found that cell cycle and translation related terms are highly significant
in loosely associated genes in comparison to tightly associated genes. We also found that splic-
ing remains a highly over-represented term regardless of tightness (Fig 4). Together with the
enriched biological processes such as “DNA-dependent regulation of transcription” and “gene
expression”, it became clear that the co-expression based predicted ECCN target gene set has a
stout emphasis on cellular signalling, transcriptional regulation, and cancer (Fig 5). Further-
more, several members of the predicted set of ECCN target genes are associated with Mende-
lian diseases as listed in the Online Mendelian Inheritance in Men dataset (OMIM) (S6 Table).
30% of the correlation/text-mining consensus genes featured such an annotation (35 of 118),
pointing to the role of the circadian clock in pathogenesis.
In particular, among our top candidate genes is a group of genes associated with tumouri-
genesis (see Table 3): Elavl1 is known to be highly expressed in several cancers and potentiates
a characteristic pro-inflammatory profile of some immunological and non-immunological dis-
eases [41], Nme1 is considered a tumour suppressor and its expression is reduced in metastatic
cancers [42], Dhx6 belongs to the DEAD box helicase superfamily and is involved in DNA re-
pair,Med1 regulates p53-dependent apoptosis [43] and Rbbp7 interacts with the tumour-sup-
pressor gene Brca1 [44] and may have a role in the regulation of cell proliferation
and differentiation.
Remarkably, we found a subset of nine genes (Apoh, Ifnar1, Sp1, Narg2, CALU, EEF1A1,
RBM14, Spag5,Med1) which are targets of both REV-ERB and ROR according to Chip-Seq ex-
periments. These two nuclear receptors are known to bind RORE elements within the promot-
er regions of target genes: while REV-ERB is an inhibitor, ROR acts as an activator. APOH
(Apolipoprotein H) and IFNAR1 (Interferon Alpha, Beta, Omega Receptor) are involved in
immune disorders [45, 46]. SP1 (Sp1 transcription factor) is also involved in immune response
and in many other cellular processes, including cell differentiation, cell growth, apoptosis, re-
sponse to DNA damage, and chromatin remodelling [19]. NARG2 (NMDA receptor regulated
2) is associated to breast cancer [47], andMed1 regulates p53-dependent apoptosis [43] and
was found to be mutated in human carcinomas with microsatellite instability [48]. The eukary-
otic translation elongation factor EEF1A1 was recently shown to mediate the alternative
A Comprehensive Regulatory Network for the Mammalian Circadian Clock
PLOS ONE | DOI:10.1371/journal.pone.0126283 May 6, 2015 19 / 28
caspase-independent cell death mechanism induced by genetically unstable tetrapolidy [49].
The sperm associated antigen 5 (SPAG5) was found to be associated with various types of can-
cer, such as cervical cancer and breast cancer [50]. Circadian regulation of these genes and as
such of the processes they regulate could be achieved via a fine-tuning of ROR/REV-ERB.
Two other circadian regulated genes identified by our study are nucleolin (Ncl) and Ddx6.
The analysis of ChIP-seq data identified these genes as targets of RORγ and REV-ERBα, β, re-
spectively. Interestingly, they were also reported to be involved in miRNA regulation [51–53].
DDX6 (RNA helicase) is found in p-bodies for mRNA degradation, needed for miRNA-
mediated silencing. NCL regulates several miRNAs including miR-21, miR-221, miR222 and
miR-103. miR-21 is defined as an oncogene and found to be overexpressed in most tumour
types [51, 54–59], whereas miR-221 and miR222 show an increased expression in human
breast cancer [60, 61]. Also, miR-222 was shown to promote resistance of cancer cells to cyto-
toxic T lymphocytes [62]. Interestingly, miR-103 which is also a target of NCL was reported to
exhibit circadian pattern [63].
Altogether, our data allowed the generation of a large network of circadian regulation. The
network was retrieved from human expression data intersected with text-mining of the bio-
medical literature, for topology refinement and de novo target identification. The novel pre-
dicted targets of the circadian clock network showed a remarkable association to cancer
driving mechanisms. One of these mechanisms is miRNA regulation. Very recent studies point
to an influence of miRNAs on the circadian clock [64–71], but only a few links on the regula-
tion of miRNAs via the circadian clock have been described [69]. NCL represents a potential
novel link via which the circadian clock, in particular RORγ, regulates the expression of miR-
NAs, with particular consequences in cancer progression.
Methods
Preprocessing
For all text-mining steps we used articles from PubMed and PubMed Central open
access subset.
Named entity recognition
Genes: For gene name recognition and normalization we used the GNAT library [72]. GNAT
uses custom dictionaries and conditional random fields (CRF) for gene name recognition and
subsequently normalises gene mentions to Entrez Gene ID’s. The system is ranked among the
first in several critical evaluations [73, 74] and achieves, according to these assessments, a preci-
sion of 82% and recall of 82% for abstracts and 54/47% for full—text articles.
Relation extraction
GeneView (a search engine which uses a comprehensively annotated database of all PubMed
abstracts and 270,000 full texts from the open PubMed Central corpus) uses the shallow lin-
guistic kernel [75] and LibSVM for relationship extraction between proteins. The model is
trained on the ensemble of five publicly available training corpora [76]. This kernel achieved
very good results in a comprehensive evaluation of nine machine learning kernels for PPI ex-
traction from text [77–79]. Furthermore, is does not use dependency information and thus is
very fast, a pre-requisite for usage in a large system such as GeneView. Data contained in Gene-
View is available at http://bc3.informatik.hu-berlin.de/. To account for species specificity, we
mapped mammalian gene identifiers to Homologene clusters [80]. To test the efficiency of
text-mining in contributing to new network generation, we first evaluated its ability to
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reconstruct a previously designed network of clock-controlled genes (CCGs) containing 121
interactions among 41 different proteins [19]. We used GeneView to extract all pairwise inter-
actions. GeneView contained evidence for 73% of all interactions described in the network test-
ed. The high sensitivity of the method encouraged us to further develop our pipeline in order
to ascertain potential new elements and interactions. We further used GeneView to collect all
interactions among the CCN and its directly interacting neighbours. After curation and filter-
ing for direct interactions, we enriched the core-clock network with 108 novel interactions sup-
ported by 132 PubMed references, which led to the extended core-clock network (ECCN)
recently reported [21]. For the ECCN, each candidate interaction is supported by up to 851
sentences (in total 4,206 sentences). We reduced the number of sentences to 580 by ranking
them by confidence and returning only 5 sentences at maximum for each candidate. Sentences
containing potentially novel PPI were ranked by the confidence of the classifier (ie. distance to
the hyperplane) and were subsequently evaluated.
Predicting interactions using coexpression data and overrepresentation
of associated gene terms
Each dataset was assessed on the number of genes they share with the ECCN and how well the
correlation coefficient distributions of known ECCN gene interactions were separated from a
background distribution of all genes, where the Wilcoxon Rank Sum test was used for quantifi-
cation. For more details on the dataset properties and selection, see S2 Text.
To find associated genes based on the correlation coefficients, we selected the 10000 highest
correlations between any ECCN gene and a non-ECCN gene as predicted interactions, thereby
considering the 1.18% most extreme correlation values.
We sought to detect and characterize only genes that were tightly associated with the
ECCN, where "tightness" was defined as the number of connections between a gene and a set of
genes. Accordingly, the comparison of the number of predicted NCRG with required tightness
1 to 10 shows the most drastic decline between 1 and 2, which quickly diminishes with rising
tightness values (Fig 4). We therefore chose to employ a tightness threshold of 2 for the re-
maining analysis. We then proceeded to find the overrepresented terms and enriched clusters
using the R package TopGO [81]. We annotated the associated genes with terms from the Ge-
netic Association Database[82], Online Mendelian Inheritance in Man database[83], Swissprot
Protein Information Resource [84], Gene Ontology [85], Pubmed and Kyoto Encyclopedia of
Genes and Genomes [86]. Significant overrepresentation was determined using p-values cor-
rected by Benjamini-Hochberg multiple testing correction (q-values).
Integration of the predicted NCRG with transcriptional features
We compared our NCRG prediction with the machine learning based prediction of clock genes
[29]. Therefore, we retrieved the top 1000 genes as of the evidence factor ranks and used the
HomoloGene database build 66 [80] to map the reported mouse genes to 993 unique entrez
genes, could then be compared to our predicted genes set.
Similarly, we tested how many of the NCRG are amongst the genes with circadian expres-
sion regulation according to recent publications [14, 27]. After combination of both lists of
mouse genes, a total of 1771 unique entrez transcripts were obtained for comparison after map-
ping via HomoloGene build 68.
An extensive collection of genes which lead to circadian clock phenotypes upon knockout
via RNAi has been described recently [28]. The reported 343 genes are categorized into double
hitters, i.e. two different pairs of siRNAs lead to a circadian clock phenotype, and single hitters,
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for which only one of the two siRNA pairs designed for each gene lead to a phenotype, where
amplitude- and phase-changes were considered as phenotype.
ChIP-seq data analysis
We employed the R package TFTargetCaller [30] to derive target gene sets for clock-related
transcription factors from experimental Chip-seq data using the method “ClosestGene”. We
used available data sets to extract target genes for REV-ERB α/β [16, 17] and for BMAL1 [12].
These include all available Chip-seq data sets for core-clock genes. Specifically, the genomic
peak locations were obtained, and the gene association score Sg,tf was calculated for all annotat-
ed refSeq genes of the mouse genome build used in the corresponding experiment. The result-
ing log2 transformed Sg,tf distributions are shown in S7 Fig. The threshold for accepting a TF—
gene association was chosen as 3, which yields the higher second gene-score peak in case of the
bimodal REV-ERB β peak set (S7B Fig), or the prominent right shoulder of the distribution for
all other peak sets. Since the genomic locations of the peaks for the ROR α/γ dataset were not
available, we used the predicted target list provided by the authors [22, 31].
Supporting Information
S1 Fig. Correlation distributions for clock network gene pairs versus random gene pairs.
Cumulative correlation value distributions obtained from the HSA dataset, shown for compari-
son with Fig 3 in the main text.
(EPS)
S2 Fig. Correlation of reported CCN interactions, ECCN interactions as compared to ran-
dom background. The Pearson ρ distributions of pairs of ECCN genes reported to interact but
excluding CCN (ECCN, green), reported pairs of CCN genes (CCN, orange), and 43 randomly
chosen genes versus all genes as background (BG, black) are shown. Pearson correlation coeffi-
cient (A, C) and mutual rank (B, D) probability density functions for known CCN interactions
and reported ECCN interactions compared with random background. Data extracted from the
HSA and HSA2 dataset are shown in (A, B), and (C, D) respectively. Shown for comparison
with Fig 3 in the main text.
(EPS)
S3 Fig. Correlation of reported ECCN interactions compared to not-reported interactions.
Pearson correlation coefficient (A, C) and mutual rank (B, D) probability density functions for
all ECCN interactions (i.e. including all CCN interactions, “reported ECCN”) compared with
all other possible pairs between ECCN genes, for which no interaction is reported (“other”).
Data extracted from the Hsa and Hsa2 dataset are shown in (A, B), and (C, D), respectively.
Shown for comparison with Fig 3 in the main text.
(EPS)
S4 Fig. Correlation of the ECCN interactions and the background. Pearson correlation coef-
ficient (A, C) and mutual rank (B, D) probability density functions for all possible pairs of
ECCN genes compared with all other possible pairs between one of the 43 ECCN genes and a
non-ECCN gene as background. Data extracted from the Hsa and Hsa2 dataset are shown in
(A, B), and (C, D), respectively. Shown for comparison with Fig 3 in the main text.
(EPS)
S5 Fig. Tightness filtering effect. The number of predicted target genes (y-axis) decreases
when increasing the minimal number of ECCN genes, with which it has to correlate (x-axis).
(EPS)
A Comprehensive Regulatory Network for the Mammalian Circadian Clock
PLOS ONE | DOI:10.1371/journal.pone.0126283 May 6, 2015 22 / 28
S6 Fig. Number of interactions (x-axis) for 32 ECCN genes (y-axis) as predicted by expres-
sion correlation. The remaining 11 ECCN genes do not feature predicted targets.
(EPS)
S7 Fig. Association scores for core clock transcription factors. Association strength scores
Stf,g between the core clock transcription factors REV-ERB α/β and BMAL1 and all refSeq
genes annotated in the corresponding genome version (mm8 [17] or mm9 otherwise) were cal-
culated using the “ClosestGene”method of the R package TFTargetCaller and the ChIP-seq
peak annotations. The number of genes with Stf,g> 0 is shown as ngene, the cutoff for accepted
TF-gene association was set to 3 as marked with a red dashed line, and the number of accepted
target genes is shown as ntarget for each individual dataset.
(EPS)
S8 Fig. Cytoscape file for Fig 7. (http://www.cytoscape.org/).
(ZIP)
S9 Fig. Cytoscape file for Fig 8. (http://www.cytoscape.org/).
(ZIP)
S1 Table. List of ECCN interactions with publication references obtained by text-mining.
(XLS)
S2 Table. Extension of the ECCN network using text-mining method.
(XLSX)
S3 Table. List of GO term annotations enriched amongst the ECCN target genes predicted
by text-mining. The table provides the term ids (“GO.ID”), the corresponding “Term”, as well
as the overrepresentation p-value after false discovery rate correction after Benjamini-Hoch-
berg (“pval”). In addition, the total number of genes annotated with the respective term is pro-
vided (“Annotated”), the number of significant annotations (“Significant”), along with the
number of annotations expected by chance in the gene set (“Expected”).
(XLSX)
S4 Table. List of KEGG pathway annotations enriched amongst the ECCN target genes pre-
dicted by text-mining. The table provides the pathway ids (“kegg.id”), the corresponding
pathway “name”, as well as the overrepresentation p-value before (“pval”) and after false dis-
covery rate correction after Benjamini-Hochberg (“fdr”).
(XLSX)
S5 Table. List of all newly predicted interactions. The columns “gene1.entrez”, “gene2.
entrez”, “gene1.symbol”, and “gene2.symbol” provide the Entrez ids and gene symbols for the
two predicted interacting genes, respectively. The Boolean flags “txtmn” and “coxp” indicate
interactions predicted by text-mining, and co-expression, respectively. “with.consensus” indi-
cates interactions involving one of the 118 consensus genes, and “overlapping” indicates the in-
teractions predicted similarly by text-mining and co-expression.
(XLSX)
S6 Table. Characterization of the 118 predicted NCRG regarding disease-related annota-
tion. Annotations from OMIM, gad, and the KEGG database were integrated in addition to
SNPs. Genetic association database (gad), KEGG pathway annotation, traits that significantly
associate with the gene as provided in the Ensemble database (gwas_trait, gwas_pval, gwas_-
pubmed_id), the number of non-synonymous SNPs found in the gene (nonsyn_count, non-
syn_norm), the Uniprot database derived protein domains (up_seq_feature), the Gene
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Ontology biological processes annotations (goterm_bp), and the Gene Reference into Function
(generif).
(XLS)
S7 Table. Characterization of the 118 NCRG regarding expression regulation by transcrip-
tion factors. The transcription factor target prediction of all 118 NCRG for both REV-ERBα/β
datasets, the BMAL1, and also the RORα/γ dataset is provided. Additionally, the phenotype
upon gene knockdown observed [28] and the prediction of “similar to clock gene” [29] are in-
cluded. The observed circadian expression and OMIM annotations are indicated.
(XLS)
S1 Text. Text-mining-based assembly and characterization of the ECCN network.
(DOCX)
S2 Text. Comparison of available co-expression databases.
(DOCX)
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